- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07692763
Evaluating the YATAC Programme (YATAC)
The Young Adult Taking Action Program: Protocol for a Pilot Randomized Controlled Trial of Cancer Rehabilitation for Young Adults
Young adults aged 18-39 years with cancer often experience physical, psychological, and social challenges that affect their participation in everyday life and their health-related quality of life. Existing cancer rehabilitation services are rarely tailored to the specific needs of this age group. The Young Adults Taking Action (YATAC) programme was developed together with young adults with cancer, healthcare professionals, and researchers to provide age-specific rehabilitation that supports young adults in managing cancer-related challenges and returning to everyday life.
The aim of this pilot randomized controlled trial is to evaluate the feasibility of conducting a larger trial of the YATAC programme in a municipal rehabilitation setting. The study will examine recruitment, retention, acceptability of randomization, data completeness, assessment burden, and adverse events. In addition, the study will provide preliminary estimates of the programme's effects on health-related quality of life and self-efficacy.
Fifty young adults aged 18-39 years who are undergoing or have completed curative-intent treatment will be recruited through municipal cancer rehabilitation services in Aarhus Municipality, Denmark. Participants will be randomly assigned to receive either the 16-week YATAC programme or usual cancer rehabilitation services. The YATAC programme includes an individual needs assessment and goal setting, followed by group-based and individual sessions addressing physical activity, fatigue, sleep and cognitive challenges, mental health, sexuality and relationships, family and friends, nutrition, and education or work. Outcomes will be assessed at baseline and at 4, 6, and 12 months after enrolment.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Maria Aagesen, PhD
- Numéro de téléphone: 004529723294
- E-mail: maagesen@health.sdu.dk
Sauvegarde des contacts de l'étude
- Nom: Marc Sampedro Pilegaard, PhD
- Numéro de téléphone: 004520722972
- E-mail: masamp@rm.dk
Lieux d'étude
-
-
-
Aarhus, Danemark, 8000
- Recrutement
- Folkesundhed (Public Health), the Municipality of Aarhus
-
Contact:
- Tenna Askjær, Physioterapist and MSc
- Numéro de téléphone: 004541859049
- E-mail: tea@aarhus.dk
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
La description
Inclusion Criteria:
- Between 18 and 39 years of age
- Are currently undergoing or have completed curative-intent cancer treatment within the past five years
- Can understand and communicate in Danish and provide informed consent independently
- Have been referred to municipal cancer rehabilitation services in the Municipality of Aarhus
Exclusion Criteria:
- Diagnosed with cancer before the age of 18
- Previously or currently receive rehabilitation
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Standard rehabilitation
|
Participants assigned to the control group will receive the standard cancer rehabilitation programme offered through Folkesundhed Aarhus.
This includes physical exercise.
|
|
Expérimental: YATAC programme
|
The YATAC 2.0 intervention will consist of a 16-week multidimensional rehabilitation programme including a mandatory needs assessment and goal-setting component, which will determine the primarily group-based components in which the young adults will participate. These components will include: 1) Physical activity, 2) Fatigue, sleep, and cognitive challenges, 3) Mental health, 4) Sexuality and relationships, 5) Family and friends, 6) Nutrition, and 7) Education and work. Each participant will be assigned a designated contact person, either a nurse or physiotherapist, who will follow the young adult throughout the programme. The contact person will conduct the needs assessments and goal-setting consultations and contribute to selected group sessions. In addition, one of the contact persons will be present during group-based sessions alongside the primary facilitator to promote continuity, coordination, and a sense of safety throughout the rehabilitation trajectory. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Recruitment rate
Délai: Baseline
|
1) Recruitment rate: Number of participants included within the planned recruitment period (July 2026-June 2027).
Data will be collected using screening and recruitment logs completed by a responsible contact professional from the Municipality of Aarhus.
|
Baseline
|
|
Acceptability of randomisation
Délai: Baseline
|
2) Acceptability of randomisation: Proportion of randomised participants who accept allocation and commence their assigned study arm.
A contact professional from the Municipality of Aarhus will complete data recruitment and allocation records.
|
Baseline
|
|
Attrition rate
Délai: Up to 12 months after baseline
|
3) Attrition rate: Proportion of participants who withdraw during the intervention period.
Data about attrition will be collected using withdrawal registrations and participant records.
|
Up to 12 months after baseline
|
|
Adverse events
Délai: Four months after baseline
|
4) Adverse events: Frequency, type, and severity of intervention-related adverse events.
and serious adverse events.
Participants will be asked to self-report intervention-related adverse events and serious adverse events.
|
Four months after baseline
|
|
Completeness of data
Délai: Four months after baseline
|
5) Completeness of data collection: Completion of primary patient-reported outcome at primary endpoint.
Questionnaire completion logs will be used.
|
Four months after baseline
|
|
Assessment burden
Délai: * Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
6) Assessment burden: Participant-reported burden and acceptability of assessments.
Short evaluation survey completed after assessments using 5-point Likert.
|
* Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Health-related quality of life
Délai: * Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
Improvements of the YATAC programme will be evaluated using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). EORTC QLQ-C30 is a cancer-specific and internationally validated instrument consisting of 30 items across 15 domains, including five functional scales, three symptom scales, six single symptom items, and a global health status/quality of life scale. Scores are linearly transformed to a 0-100 scale according to the EORTC scoring manual. Higher scores on functional and global health status scales indicate better functioning and HRQoL, whereas higher symptom scores indicate greater symptom burden. The primary endpoint of the intervention will be global health status/quality of life four months after baseline. The remaining outcomes from the EORTC QLQ-C30 include: physical, role, emotional, cognitive, and social functioning; fatigue; pain; dyspnoea; and insomnia. |
* Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
|
AYA-specific quality of life
Délai: * Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
Improvements of the YATAC programme will also be evaluated using the AYA-specific quality of life questionnaire, which is a supplementary module in the EORTC QLQ-AYA30 developed for adolescents and young adults with cancer aged 14-39 years. The questionnaire includes five multi-item scales assessing: 1) Activity limitations, 2) Worry about cancer and the future, 3) Self-esteem, 4) Relationships, and 5) Positive changes. In addition, nine single items address domains such as work/education, romantic and sexual life, relocation, caregiving responsibilities, and diet restrictions. Scores are transformed to a 0-100 scale, where higher scores reflect greater symptom burden, except for positive changes, where higher scores indicate better functioning The outcomes from EORTC QLQ-A include: Activity limitations, worry about cancer and the future, self-esteem, relationships, positive changes, and work/education, romantic and sexual life, relocation. |
* Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
|
Self-Efficacy
Délai: * Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
Improvements of the YATAC programme will also be evaluated using the Self-Efficacy for Managing Chronic Disease 6-item Scale (SES6G) consisting of six items rated on a 10-point Likert scale ranging from 1 ("not at all confident") to 10 ("totally confident").
The mean score across items represents the overall self-efficacy score, with higher scores indicating greater confidence in managing health-related challenges.
|
* Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Embedded qualitative study
Délai: Up to four months baseline
|
An embedded qualitative study will be conducted alongside the pilot RCT to explore barriers and facilitators related to recruitment, participation, retention, and acceptability of participation in rehabilitation intervention trials among young adults with cancer.
|
Up to four months baseline
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Marc Sampedro Pilegaard, PhD, Social Medicine and Rehabilitation, Gødstrup Hospital
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- Young Adult Taking ACtion
- R379-A22563 (Autre subvention/numéro de financement: Danish Cancer Society)
- 23-20-0478 (Autre subvention/numéro de financement: The Aase and Ejnar Danielsen Foundation)
- R95-A4572 (Autre subvention/numéro de financement: The Central Region of Denmark)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Délai de partage IPD
Critères d'accès au partage IPD
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .